Only one RCT comparing propofol-based TIVA versus sevoflurane anesthesia in breast cancer surgery did not find differences in 2-year recurrence-free and overall survival, although TIVA effectively inhibited the release of vascular endothelial growth factor (VEGF) [28]. Here, VEGFA is linked to breast carcinoma.